reports
- GlobalData Healthcare Department
Sanofi India Ltd (SANOFI) - Financial Analysis Review
Sanofi India Ltd (SANOFI) - Financial Analysis Review Summary Sanofi India Ltd (Sanofi India), formerly Aventis Pharma Ltd, a subsidiary of Sanofi, is a manufacturer of medicines for the treatment of patients in several therapeutic areas. The company’s product portfolio includes ramipril, amlodipine, hydrochlorothiazide, frusemide, spironolactone, frusemide, piperacillin, tazobactam, cefpirome sulphate, meropenem, gemifloxacin, azithromycin, ofloxacin, levofloxacin, rabeprazole, and domperid...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.